PointState Capital’s Radius Health, Inc. RDUS Stock Holding History

PointState Capital’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-871,500	Closed	-$33.6M	–	193
2017 Q3	$33.6M	Buy	+871,500	New	+$34.2M	0.29%	73
2017 Q1	–	Sell	-300,000	Closed	-$11.4M	–	169
2016 Q4	$11.4M	Sell	300,000 -182,500	-38%	-$8.68M	0.16%	83
2016 Q3	$26.1M	Buy	+482,500	New	+$24.5M	0.27%	67
2016 Q2	–	Sell	-130,000	Closed	-$4.09M	–	140
2016 Q1	$4.09M	Buy	130,000 +10,000	+8%	+$346K	0.11%	65
2015 Q4	$7.38M	Sell	120,000 -55,000	-31%	-$3.47M	0.19%	58
2015 Q3	$12.1M	Sell	175,000 -425,000	-71%	-$29.5M	0.34%	48
2015 Q2	$40.6M	Buy	+600,000	New	+$28M	0.47%	43

Other funds holding RDUS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PointState Capital's RDUS Position: Q4 2017 in Review

PointState Capital sold out of Radius Health, Inc. (RDUS) in Q4 2017, closing a stake of 871,500 shares — an estimated $33.6M sold.

PointState Capital first reported a position in RDUS in Q2 2015 and held it in 7 quarters. The position peaked at $40.6M in Q2 2015. 143 funds tracked by Wall St. Rank hold RDUS as of Q4 2017.

PointState Capital reported no remaining Radius Health, Inc. position as of Q4 2017 after selling out during the quarter.
PointState Capital sold 871,500 Radius Health, Inc. shares in Q4 2017, an estimated $33.6M.
PointState Capital first reported a position in Radius Health, Inc. in Q2 2015 and held it in 7 quarters.
PointState Capital's Radius Health, Inc. position peaked at $40.6M in Q2 2015.
143 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q4 2017.

Based on PointState Capital's 13F filing for Q4 2017, filed 14 Feb 2018.